Skip to content

FORMULATION RD

Vici Health Sciences

Elkridge, MarylandReviewed Mar 26, 2026

R&D center offering formulation development, analytical method validation and stability testing.

MOQ
Not publicly disclosed
LEAD TIME
Not publicly disclosed

Overview

Vici Health Sciences operates a pharmaceutical R&D center of excellence in Elkridge, Maryland, providing end-to-end drug and supplement development services. The company holds cGMP, GLP, and DEA (Schedules I-V) certifications. Vici's team has developed over 50 formulations, participated in more than 30 clinical trials, and secured FDA approvals for over 15 ANDAs. For the nutraceutical sector, Vici offers formulation development, analytical method validation, stability testing, cGMP clinical supplies manufacturing, and FDA regulatory consulting. Their pharmaceutical-grade approach to supplement R&D provides a higher bar of analytical rigor than typical contract manufacturers. Vici also joined the Contract Laboratory Network, making their capabilities discoverable to brands seeking independent testing and development partners.

Certifications

0 of 3 certifications independently confirmed. What this means

Capabilities

PRODUCT TYPES
Formulation Development · Analytical Method Validation · Stability Testing · Clinical Supplies Manufacturing
CAPABILITIES
Custom formula development · Independent consulting · Clinical study design or supplies · Regulatory or label compliance · Stability, lab testing or quality assurance

Sources

What we couldn't verify

We did not visit this company on site. See the limits that apply to every listing.

  • Primarily a pharmaceutical R&D firm; nutraceutical work is one vertical among several
  • All certifications (cGMP, GLP, DEA) are self-reported
  • Pricing likely reflects pharmaceutical-grade service levels

Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires

The connection map between Vici Health Sciences and other vendors, capabilities, and certifications is in the manufacturer atlas.

Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →

Interested in Vici Health Sciences?

Tell us about your project and we'll help you determine if this formulation partner is a good fit.

Educational information only. Not legal, regulatory, or professional advice. Inventory Ready provides independent assessments based on publicly available information. See Terms for details.